Detail

Back

NBD Seminar Series: Why do brain cancers resist therapies? Can human brain organoid models help address this unmet need?

Abstract:

In this talk, Cedric will present some recent data from his group showing that the human brain microenvironment induces tumour cell plasticity and changes their sensitivity to chemo-radiotherapies. He will also show examples of leveraging human iPSC brain models to predict chemotherapeutic toxicities.

Venue:Amphitheatre, Level 2, Duke-NUS

Host: Asst Prof Alfred Sun
Principal Investigator
Neuroscience & Behavioural Disorders Programme, Duke-NUS
Contact Person:

Joyceline Ng (joyceline.ng@duke-nus.edu.sg)
Neuroscience & Behavioural Disorders Programme, Duke-NUS



Date and Time


06 Mar 2024 @ 14:30 - 06 Feb 2024 @ 15:30

Speaker


Cedric Bardy [SAHMRI] [JAB00917] copy 2

Dr Cedric Bardy
Professor and ARC Future Fellow
SAHMRI and Flinders University

Cedric obtained a PhD from the University of Sydney (2008) and his postdoctoral training from the Pasteur Institute (2008-2011) and the Salk Institute (2011-2016). He then established his research group at the iconic South Australian Health and Medical Research Institute.

Cedric’s team is dedicated to finding therapeutics for adult/pediatric neurodegeneration and brain cancer and plays a leading role advancing human brain models in vitro.

www.bardylab.com

Browser not supported

Modern websites need modern browsers

To enjoy the full experience, please upgrade your browser

Try this browser